The Association of Folic Acid, Iron Nutrition during Pregnancy and Congenital Heart Disease in Northwestern China: A Matched Case-Control Study.

Background : The purpose of this study was to investigate the relationship between folic acid and iron nutrition during pregnancy and congenital heart disease (CHD) in the offspring. Methods : Conditional logistic regression models and nonlinear mixed-effects models were used to analyze the effects of folic acid and iron nutrition during pregnancy on CHD in offspring. Results : After adjusting for confounders, folic acid or iron supplementation during pregnancy reduced the risk for fetal CHD ( OR = 0.60 (0.45, 0.82) or 0.36 (0.27, 0.48)). Similarly, dietary iron intake during pregnancy (≥29 mg/d) was associated with a reduced risk of fetal CHD ( OR = 0.64 (0.46, 0.88)). Additionally, compared with women who only supplemented folic acid ( OR = 0.59 (0.41, 0.84)) or iron ( OR = 0.32 (0.16, 0.60)), women who supplemented both folic acid and iron had lower risk for newborns with CHD ( OR = 0.22 (0.15, 0.34)). Similarly, compared with women who only supplemented folic acid ( OR = 0.59 (0.41, 0.84)) or higher dietary iron intake (≥29 mg/d) ( OR = 0.60 (0.33, 1.09)), women who supplemented both folic acid and higher dietary iron intake (≥29 mg/d) had lower risk for the newborn with CHD ( OR = 0.41 (0.28, 0.62)). The combined effects were significant in the multiplication model ( OR = 0.35 (0.26, 0.48) or 0.66 (0.50, 0.85)) but not in the additive model. Conclusions : Our study found that folic acid and iron nutrition during pregnancy were associated with a reduced risk of CHD in the offspring and confirmed a statistically significant multiplicative interaction between folic acid and iron nutrition on the reduced risk of CHD in offspring.